Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis

被引:25
作者
Gould, Carolyn V.
Sniegowski, Paul D.
Shchepetov, Mikhail
Metlay, Joshua P.
Weiser, Jeffrey N.
机构
[1] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
[4] Vet Adm Med Ctr, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/AAC.00336-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The occurrence of mutator phenotypes among laboratory-generated and clinical levofloxacin-resistant strains of Streptococcus pneumoniae was determined using fluctuation analysis. The in vitro selection for levofloxacin-resistant mutants of strain D39, each with point mutations in both gyrA and parC or parE, was not associated with a significant change in the mutation rate. Two of eight clinical isolates resistant to levofloxacin (MIC, > 8 mu g/ml) had estimated mutation rates of 1.2 x 10(-7) and 9.4 x 10(-8) mutations per cell division, indicating potential mutator phenotypes, compared to strain D39, which had an estimated mutation rate of 1.4 x 10(-8) mutations per cell division. The levofloxacin-resistant isolates with the highest mutation rates showed evidence of dysfunctional mismatch repair and contained missense mutations in mat genes at otherwise highly conserved sites. The association of hypermutability in levofloxacin-resistant S. pneumoniae clinical isolates with mutations in DNA mismatch repair genes provides further evidence that mismatch repair mutants may have a selective advantage in the setting of antibiotic pressure, facilitating the development of further antibiotic resistance.
引用
收藏
页码:3225 / 3229
页数:5
相关论文
共 38 条
[1]   HETERODUPLEX DNA MISMATCH REPAIR SYSTEM OF STREPTOCOCCUS-PNEUMONIAE - CLONING AND EXPRESSION OF THE HEXA GENE [J].
BALGANESH, TS ;
LACKS, SA .
JOURNAL OF BACTERIOLOGY, 1985, 162 (03) :979-984
[2]   Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae [J].
Balsalobre, L ;
Ferrándiz, MJ ;
Liñares, J ;
Tubau, F ;
de la Carnpa, AG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2072-2081
[3]   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[4]   Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients [J].
del Campo, R ;
Morosini, MI ;
de la Pedrosa, EGG ;
Fenoll, A ;
Muñoz-Almagro, C ;
Máiz, L ;
Baquero, F ;
Cantón, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (05) :2207-2214
[5]   Fluoroquinolone resistance in Streptococcus pneumoniae:: Evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation [J].
Gillespie, SH ;
Voelker, LL ;
Ambler, JE ;
Traini, C ;
Dickens, A .
MICROBIAL DRUG RESISTANCE, 2003, 9 (01) :17-24
[6]   Costs and benefits of high mutation rates: Adaptive evolution of bacteria in the mouse gut [J].
Giraud, A ;
Matic, I ;
Tenaillon, O ;
Clara, A ;
Radman, M ;
Fons, M ;
Taddei, F .
SCIENCE, 2001, 291 (5513) :2606-2608
[7]   Management of community-acquired pneumonia in the era of pneumococcal resistance -: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group [J].
Heffelfinger, JD ;
Dowell, SF ;
Jorgensen, JH ;
Klugman, KP ;
Mabry, LR ;
Musher, DM ;
Plouffe, JF ;
Rakowsky, A ;
Schuchat, A ;
Whitney, CG .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) :1399-1408
[8]   Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong [J].
Ho, PL ;
Que, TL ;
Tsang, DNC ;
Ng, TK ;
Chow, KH ;
Seto, WH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1310-1313
[9]  
HOOPER DC, 2001, CLIN INFECT DIS S1, V32, P9
[10]   High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA [J].
Janoir, C ;
Zeller, V ;
Kitzis, MD ;
Moreau, NJ ;
Gutmann, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2760-2764